Elina Eriksson

791 total citations
15 papers, 653 citations indexed

About

Elina Eriksson is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Elina Eriksson has authored 15 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Elina Eriksson's work include Cancer Genomics and Diagnostics (4 papers), Cell Adhesion Molecules Research (3 papers) and Cancer-related Molecular Pathways (3 papers). Elina Eriksson is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cell Adhesion Molecules Research (3 papers) and Cancer-related Molecular Pathways (3 papers). Elina Eriksson collaborates with scholars based in Sweden, Germany and Japan. Elina Eriksson's co-authors include Gert Auer, Edward Azavedo, Arne Wallgren, Torbjörn Caspersson, Martin Bäckdahl, H. Schimmelpenning, Bo Franzén, Anders Zetterberg, Stig Linder and Ulla Enberg and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal Of Pathology and International Journal of Cancer.

In The Last Decade

Elina Eriksson

15 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elina Eriksson Sweden 13 287 286 259 129 72 15 653
Cindy A. Pise-Masison United States 5 497 1.7× 320 1.1× 158 0.6× 96 0.7× 61 0.8× 6 820
Andrew Berchuck United States 10 560 2.0× 203 0.7× 375 1.4× 249 1.9× 149 2.1× 11 1.1k
Saima Hassan Canada 13 400 1.4× 175 0.6× 384 1.5× 110 0.9× 63 0.9× 27 735
Eva Colás Spain 21 624 2.2× 408 1.4× 231 0.9× 69 0.5× 103 1.4× 42 1.2k
Thomas Waerner Germany 10 636 2.2× 150 0.5× 306 1.2× 50 0.4× 83 1.2× 13 866
B. Lisboa Germany 12 203 0.7× 376 1.3× 474 1.8× 54 0.4× 207 2.9× 23 788
Jan Willem F Dierssen Netherlands 6 321 1.1× 179 0.6× 318 1.2× 189 1.5× 71 1.0× 7 613
Christine To Canada 9 391 1.4× 196 0.7× 323 1.2× 43 0.3× 22 0.3× 11 708
John Cairns United Kingdom 7 455 1.6× 268 0.9× 835 3.2× 75 0.6× 188 2.6× 13 1.1k
S. Edgerton United States 6 269 0.9× 118 0.4× 292 1.1× 61 0.5× 39 0.5× 8 560

Countries citing papers authored by Elina Eriksson

Since Specialization
Citations

This map shows the geographic impact of Elina Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elina Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elina Eriksson more than expected).

Fields of papers citing papers by Elina Eriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elina Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elina Eriksson. The network helps show where Elina Eriksson may publish in the future.

Co-authorship network of co-authors of Elina Eriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Elina Eriksson. A scholar is included among the top collaborators of Elina Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elina Eriksson. Elina Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wangsa, Darawalee, Kerstin Heselmeyer‐Haddad, Elina Eriksson, et al.. (2009). Fluorescence in Situ Hybridization Markers for Prediction of Cervical Lymph Node Metastases. American Journal Of Pathology. 175(6). 2637–2645. 20 indexed citations
2.
Zang, Hong, Lena Sahlin, Britt Masironi, Elina Eriksson, & Angelica Lindén Hirschberg. (2007). Effects of Testosterone Treatment on Endometrial Proliferation in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism. 92(6). 2169–2175. 52 indexed citations
3.
Stoltzfus, Patricia, Sirpa Salo, Elina Eriksson, et al.. (2004). Laminin-5 γ2 Chain Expression Facilitates Detection of Invasive Squamous Cell Carcinoma of the Uterine Cervix. International Journal of Gynecological Pathology. 23(3). 215–222. 13 indexed citations
4.
Blegen, Harald, Β. Michael Ghadimi, Anders Zetterberg, et al.. (2001). Genetic Instability Promotes the Acquisition of Chromosomal Imbalances in T1b and T1c Breast Adenocarcinomas. Analytical Cellular Pathology. 22(3). 123–131. 12 indexed citations
5.
Dalberg, Kristina, Elina Eriksson, Ulla Enberg, Magnus Kjellman, & Martin Bäckdahl. (2000). Gelatinase A, Membrane Type 1 Matrix Metalloproteinase, and Extracellular Matrix Metalloproteinase Inducer mRNA Expression: Correlation with Invasive Growth of Breast Cancer. World Journal of Surgery. 24(3). 334–340. 70 indexed citations
6.
Bucht, Elisabet, Haiqin Rong, Ylva Pernow, et al.. (1998). Parathyroid hormone-related protein in patients with primary breast cancer and eucalcemia.. PubMed. 58(18). 4113–6. 23 indexed citations
7.
Franzén, Bo, Stig Linder, Ayodele Alaiya, et al.. (1997). Analysis of polypeptide expression in benign and malignant human breast lesions. Electrophoresis. 18(3-4). 582–587. 81 indexed citations
8.
Franzén, Bo, Gert Auer, Ayodele Alaiya, et al.. (1996). Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors. International Journal of Cancer. 69(5). 408–414. 37 indexed citations
9.
Engel, Georg, et al.. (1994). Correlation between stromelysin‐3 mRNA level and outcome of human breast cancer. International Journal of Cancer. 58(6). 830–835. 67 indexed citations
10.
Eriksson, Elina, H. Schimmelpenning, Ulla Aspenblad, Anders Zetterberg, & Gert Auer. (1994). Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease. Human Pathology. 25(11). 1228–1233. 45 indexed citations
11.
Schimmelpenning, H., Elina Eriksson, Anders Zetterberg, & Gert Auer. (1994). Association of immunohistochemical p53 tumor suppressor gene protein overexpression with prognosis in highly proliferative human mammary adenocarcinomas. World Journal of Surgery. 18(6). 827–832. 12 indexed citations
12.
Schimmelpenning, H., Elina Eriksson, Bo Franzén, Anders Zetterberg, & Gert Auer. (1993). Prognostic value of the combined assessment of proliferating cell nuclear antigen immunostaining and nuclear DNA content in invasive human mammary carcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 423(4). 273–279. 17 indexed citations
13.
Schimmelpenning, H., Elina Eriksson, Sture Falkmer, et al.. (1992). Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 420(5). 433–440. 25 indexed citations
14.
Eriksson, Elina, H. Schimmelpenning, Claes Silfverswärd, & Gert Auer. (1992). Immunoreactivity with monoclonal antibody A-80 and nuclear DNA content in benign and malignant human breast disease. Human Pathology. 23(12). 1366–1372. 11 indexed citations
15.
Auer, Gert, Elina Eriksson, Edward Azavedo, Torbjörn Caspersson, & Arne Wallgren. (1984). Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.. PubMed. 44(1). 394–6. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cindy A. Pise-Masison Breakdown of academic impact, for papers by Andrew Berchuck Breakdown of academic impact, for papers by Saima Hassan Breakdown of academic impact, for papers by Eva Colás Breakdown of academic impact, for papers by Thomas Waerner Breakdown of academic impact, for papers by B. Lisboa Breakdown of academic impact, for papers by Jan Willem F Dierssen Breakdown of academic impact, for papers by Christine To Breakdown of academic impact, for papers by John Cairns Breakdown of academic impact, for papers by S. Edgerton
Rankless by CCL
2026